Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
AVTE | Aerovate Therapeutics, Inc. | Director | $50.9M | -$334K | -0.65% | Jun 5, 2024 |
QTTB | Q32 Bio Inc. | Director | $1.23M | Apr 1, 2024 | ||
SURF | Surface Oncology, Inc. | Director | Sep 8, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|